Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 4/20 | 0.37 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA6 | P23280 | 1/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 4/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 2/20 | 0.32 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.32 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.32 |
| ▸ | AR | P10275 | 1/20 | 0.32 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.32 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21217710 | 0.84 | MEN1 (0.39) | CA1CA2CA4CA6PDK2 | |
| SCHEMBL16219720 | 0.84 | PDK2 (0.40) | CA1CA2CA4CA6PDK2 | |
| SCHEMBL17264183 | 0.82 | PDK2 (0.35) | CA1CA2CA4CA6PDK2 | |
| SCHEMBL15870875 | 0.82 | PDK2 (0.35) | CA1PDK2TP53MAPTPOLB | |
| SCHEMBL15870872 | 0.81 | CYP1A2 (0.31) | CYP1A2 | |
| SCHEMBL12377014 | 0.80 | PDK2 (0.38) | PDK2PGRARAKR1A1AKR1B1 | |
| SCHEMBL19152864 | 0.79 | CYP2A6 (0.39) | CA1CA2CA4CA6PDK2 | |
| SCHEMBL18770230 | 0.78 | CA1 (0.37) | CRHR1CA1CA2CA4CA6 | |
| SCHEMBL19885216 | 0.77 | ESR1 (0.30) | — | |
| SCHEMBL16219705 | 0.77 | EGFR (0.32) | CA1CA2CA4CA6PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230322656-A1 | ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE HAVING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230322656-A1 | ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE HAVING SAME | PIEZO1, OR10J3, ODC1 | CRHR1 4634/4885GRM2 2272/4885CA1 2059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.